Franklin Genomic Advancements Fund A -H1 Fonds
6,57
EUR
-0,05
EUR
-0,76
%
NAV
Werbung
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Medpace Holdings Inc | US58506Q1094 | 5,69% |
| Vertex Pharmaceuticals Inc | US92532F1003 | 5,35% |
| Danaher Corp | US2358511028 | 5,32% |
| Regeneron Pharmaceuticals Inc | US75886F1075 | 5,21% |
| Thermo Fisher Scientific Inc | US8835561023 | 5,06% |
| Eli Lilly and Co | US5324571083 | 4,77% |
| Krystal Biotech Inc | US5011471027 | 4,34% |
| Natera Inc | US6323071042 | 3,91% |
| Samsung BioLogics Co Ltd | KR7207940008 | 3,71% |
| AstraZeneca PLC ADR | US0463531089 | 2,65% |
| Sonstige | 53,98% |